Comparison of levofloxacin-based triple therapy and levofloxacin plus Tetracycline-based quadruple therapy

被引：0
|
作者：
Tseng, Kuo-Lun [1 ]
Wu, Tzung-Shiun [1 ]
Chang, Lin-Li [2 ]
Wu, Jeng-Yih [3 ]
Wu, Deng-Chyang [4 ]
Wang, Wen-Ming [3 ]
机构：
[1] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan
[3] Kaohsiung Municipal Tatung Hosp, Div Internal Med, Kaohsiung, Taiwan
[4] Kaohsiung Municipal Hsiaokang Hosp, Div Internal Med, Kaohsiung, Taiwan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1640
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [21] Efficacy of Levofloxacin-based Triple Therapy as a Second-line Therapy for H. pylori Eradication After Triple Therapy Failure
    Mahachai, Varocha
    Thongbai, Thirada
    Vilaichone, Ratha-korn
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S43 - S43
  • [22] Eradication therapy against Helicobacter pylori in Japan - efficacy of levofloxacin-based triple therapy as the third-line therapy
    Kobe, Daisuke
    Nakatani, Toshiya
    Fujinaga, Yukihisa
    Seki, Kenichiro
    Saikawa, Soichiro
    Sawada, Yasuhiko
    Nagamatsu, Shinsaku
    Matsuo, Hideki
    Kikuchi, Eiryo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 407 - 408
  • [23] Efficacy of levofloxacin-based triple therapy as a second-line therapy for H. pylori eradication after triple therapy failure
    Mahachai, Varocha
    Thongbai, Thirada
    Vilaichone, Ratha-Korn
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 63 - 63
  • [24] Levofloxacin-based triple therapy for Helicobacter pylori re-treatment:: Role of bacterial resistance
    Perna, F.
    Zullo, A.
    Ricci, C.
    Hassan, C.
    Morini, S.
    Vaira, D.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (11) : 1001 - 1005
  • [25] Levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication:: Update
    Finizio, R
    Nista, EC
    Candelli, M
    Zocco, MA
    Ojetti, V
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. HELICOBACTER, 2005, 10 (05) : 528 - 528
  • [26] Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
    Kuo, Chao-Hung
    Hu, Hung-Ming
    Kuo, Fu-Chen
    Hsu, Ping-I.
    Chen, Angela
    Yu, Fang-Jung
    Tsai, Pei-Yun
    Wu, I. -Chen
    Wang, Sheng-Wen
    Li, Chia-Jung
    Weng, Bi-Chuang
    Chang, Lin-Li
    Jan, Chang-Ming
    Wang, Wen-Ming
    Wu, Deng-Chyang
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) : 1017 - 1024
  • [27] Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
    Liao, Jingxian
    Zheng, Qing
    Liang, Xiao
    Zhang, Wei
    Sun, Qinjuan
    Liu, Wenzhong
    Xiao, Shudong
    Graham, David Y.
    Lu, Hong
    [J]. HELICOBACTER, 2013, 18 (05) : 373 - 377
  • [28] 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication
    Nista, EC
    Cazzato, IA
    Di Caro, S
    Candelli, M
    Ojetti, V
    Gabrielli, M
    Santarelli, L
    Nista, R
    Fini, L
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A359 - A359
  • [29] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [30] Possibility of Levofloxacin-Based Triple Therapy for H. pylori Eradication Among Inhabitants of Eastern Siberia
    Tsukanov, V. V.
    Rzhavicheva, O. S.
    Kupershtein, E. Y.
    Sharypova, V. N.
    Tonkikh, J. L.
    [J]. HELICOBACTER, 2009, 14 (04) : 406 - 406
12345